SynCardia Systems Scores $19M for Artificial Heart
SynCardia Systems Inc., maker of an artificial heart used as bridge to transplant for people suffering from end-stage heart failure, has raised $19 million in new capital. The funding includes a $15 million structured financing from Athyrium Opportunities Fund, as well as a $4 million follow-on equity investment from existing shareholders.
20 March 2013•4 mins read
